drugset / Trial / NCT00875017

Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers

NCT00875017 ↗

Phase 1 Completed 31 enrolled Shire
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the absorption of dietary phosphorus following a single dose with lanthanum carbonate (1000mg) and a single dose of sevelamer carbonate (2400mg).

Timeline

Start
2009-04-20
Primary completion
2009-06-16
Completion
2009-06-16

Outcome

Met primary endpoint

paper Lanthanum carbonate decreased net phosphate absorption by 45% (net absorption, 156.0 ± 14.2 mg) compared with 21% (net absorption, 221.8 ± 14.1 mg) for sevelamer carbonate (P < 0.001). PMID 21354682 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lanthanum Carbonate Other / unclassified 1000 mg —
Comparator Sevelamer Other / unclassified 2400 mg —